jeni health.See the demoJoin the waitlist
The clinician's morning list: three records asking to be read, each carrying how long it has waited
01For clinics

What changes at the follow-up.

Escalate, hold at this dose, or step down: you make that call every four to eight weeks, and you make it from what the patient can remember about weeks you did not see. This is what it looks like when those weeks are in front of you instead.

The decision

The interval is the part nobody observed.

Four weeks of one patient's record on a single page: what happened, what changed, what is still open, and the weight line
One patient's four weeks, from the demo clinic. Synthetic records, the shipping screen.

A clinic already knows what it prescribed and what the scale said last time. What it cannot see is the shape of the weeks in between: which doses actually got taken, when the nausea landed relative to them, whether the protein floor was ever met. Those are the inputs to the next titration decision, and today they arrive as a fifteen-minute recollection given by someone who is trying to be helpful.

Jeni is the patient’s own record of that interval, composed into one page you read before you walk in, with the patients whose records need a read surfaced first.

Enrollment, not installationYou hand a named patient a one-time code. They enter it and choose what to share. Nothing to migrate, no portal for your staff to learn, and no list of your patients leaving the practice.
One short list each morningRanked by what needs a read: a correction the patient filed, a follow-up past its date, a pattern in the record. Each carries how long it has waited. Everyone quiet is one collapsed line, which is most of your panel.
The four weeks, before the roomThe plan on file · what happened · what changed · what is still open · what to discuss at the visit. Doses, symptoms and weight on a single axis. The timing is stated; the cause never is.
What we need

Three things, and they are not small.

Better said before a call than after one.

A clinician who will put their name on the planEvery instruction a patient receives traces to a named clinician who recorded it, at that dose, on that date. This is the constraint the whole product is built around, and it is why there is no way for Jeni to say anything to your patient that you did not write.
Your titration pathway as you actually run itNot the version in the guideline; the one you practice. It becomes the protocol the patient's app composes their day from, versioned, so it is always answerable which one a given patient was on.
Patients who will use a phoneiOS today. If a meaningful share of your panel is Android, we are not ready for you yet, and that is worth establishing in the first ten minutes rather than the third month.
What we don't do

Five things we will not do.

We do not make clinical decisionsNobody at Jeni answers a clinical question. Not once, not as a favor, not because the answer seemed obvious. It is a product constraint, not a policy we could quietly change.
Nothing here watches your patientsNothing notices a patient who goes quiet, nothing alerts, and nothing is followed up automatically. Jeni is read before a visit. It is the first thing we would build if a clinic told us it mattered, and we are not going to pretend it already exists.
Your patient hears from you, or from nobodyThere is no clinic-to-patient message channel at all. The program is yours and carries your practice. We are the runtime, not the relationship.
Your panel is never sold anythingNo upsells, no marketplace, no supplements, no advertising. Their phone is not a channel we rent out.
We do not claim outcomes we have not measuredWhether between-visit support raises long-term persistence has not been established in a trial by anyone, including us. See the evidence page for what the literature does and does not support.
Fit

Who this is for, and who it isn’t.

No clinic is running on Jeni today. The first ones will shape it in their own protocols before it is sold to anyone, which makes being specific about fit cheap for us and useful for you, including where we are the wrong answer.

A good fitPhysician- or NP-owned, where the person who signs also practices. Roughly 300 to 1,500 active patients on therapy. A membership or program model, so retention is the business rather than a metric. Between-visit work currently absorbed by staff who have another job.
Too earlyFewer than about a hundred patients on therapy. The work is real but it still fits in someone's head, and you would be paying for a system to solve a problem you can still hold. Talk to us anyway: at this stage the conversation is worth more to us than the deal.
Not yetHealth systems, primary care generally, and payer-led programs. The same problem exists at greater scale, and a layer that works in the least-resourced setting travels upward more easily than the reverse, but not before this works.
The wrong companyIf what you need is patient acquisition. We do not do it, and the vendors who do it well are not us. Likewise if a refill is the whole of the relationship: there is no interval to read.

Segment definition from the Jeni Health company plan, 2026.

Talk to us

Escalate, hold, or step down?

Ten weeks on therapy, six on Jeni. Nine of ten doses marked taken. Queasy in the two days after each of the last three. Protein floor met on five of twenty-four logged days, all five before the step-up. That is the record the demo ends on, and the reading is yours. Twenty minutes with the person who built it: tell us where it would break in your practice.

Book 20 minutesOpen the demo clinic →